SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Albireo Pharma Q1 EPS $(2.230) Misses $(1.360) Estimate, Sales $1.549M Beat $1.030M Estimate

Albireo Pharma (NASDAQ:ALBO) reported quarterly losses of $(2.230) per share which missed the analyst consensus estimate of $(1.360) by 63.97 percent. This is a 60.43 percent decrease over losses of $(1.390) per share

Benzinga · 05/07/2020 11:54

Albireo Pharma (NASDAQ:ALBO) reported quarterly losses of $(2.230) per share which missed the analyst consensus estimate of $(1.360) by 63.97 percent. This is a 60.43 percent decrease over losses of $(1.390) per share from the same period last year. The company reported quarterly sales of $1.549 million which beat the analyst consensus estimate of $1.030 million by 50.39 percent. This is a 171.75 percent increase over sales of $570.000 thousand the same period last year.